Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia. [electronic resource]
Producer: 20071031Description: 1377-84 p. digitalISSN:- 0007-1188
- Animals
- Apoptosis -- drug effects
- Blood-Brain Barrier
- Brain Ischemia -- drug therapy
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Enzyme-Linked Immunosorbent Assay
- Epoetin Alfa
- Erythropoietin -- administration & dosage
- Hematinics -- administration & dosage
- Hematocrit
- Infarction, Middle Cerebral Artery -- drug therapy
- Male
- Microglia -- drug effects
- Neuroprotective Agents -- administration & dosage
- Rats
- Rats, Wistar
- Recombinant Proteins
- Stroke -- drug therapy
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.